COVID-19 (severe/critical) |
Laboratory Findings |
Creatine kinase [1 unit increase vs. Not applicable] |
Weighted Mean Difference: 23.550 (17.080-30.020)
|
Xu
|
|
|
COVID-19 (severe/critical) |
Laboratory Findings |
LDH [1 unit increase vs. Not applicable] |
Standardized mean difference: 2.000 (1.200-2.800)
|
Xu
|
|
|
COVID-19 (severe/critical) |
Laboratory Findings |
Procalcitonin [1 unit increase vs. Not applicable] |
Weighted Mean Difference: 0.160 (0.040-0.280)
|
Xu
|
|
|
COVID-19 (severe/critical) |
Laboratory Findings |
CRP [1 unit increase vs. Not applicable] |
Standardized mean difference: 2.110 (0.710-3.510)
|
Xu
|
|
|
COVID-19 (severe/critical) |
Laboratory Findings |
Creatinine [1 unit increase vs. Not applicable] |
Weighted Mean Difference: 8.320 (1.630-18.280)
|
Xu
|
|
|
COVID-19 (severe/critical) |
Laboratory Findings |
LDH [1 unit increase vs. Not applicable] |
Weighted Mean Difference: 3.930 (2.010-5.860)
|
Xu
|
|
|
COVID-19 (severe/critical) |
Laboratory Findings |
AST [1 unit increase vs. Not applicable] |
Weighted Mean Difference: 20.600 (6.810-34.400)
|
Xu
|
|
|
COVID-19 (severe/critical) |
Laboratory Findings |
ALT [1 unit increase vs. Not applicable] |
Weighted Mean Difference: 16.970 (2.180-31.760)
|
Xu
|
|
|
COVID-19 (severe/critical) |
Laboratory Findings |
Neutrophils [1 unit increase vs. Not applicable] |
Weighted Mean Difference: 2.920 (1.330-7.170)
|
Xu
|
|
|
COVID-19 (severe/critical) |
Laboratory Findings |
WBC [1 unit increase vs. Not applicable] |
Weighted Mean Difference: 1.760 (0.310-3.220)
|
Xu
|
|
|
COVID-19 (severe/critical) |
Symptoms |
Dyspnea [Present vs. Not present] |
Odds ratio: 8.830 (2.820-27.670)
|
Xu
|
|
|
COVID-19 (severe/critical) |
Symptoms |
Body temperature [Fever present vs. Not present] |
Odds ratio: 2.110 (1.110-4.020)
|
Xu
|
|
|
COVID-19 (severe/critical) |
Vital Signs |
Respiratory rate [1 unit increase vs. Not applicable] |
Weighted Mean Difference: 5.290 (2.560-8.010)
|
Xu
|
|
|
COVID-19 (severe/critical) |
Comorbidities |
COPD [Present vs. Not present] |
Odds ratio: 3.560 (1.330-9.540)
|
Xu
|
|
|
COVID-19 (severe/critical) |
Comorbidities |
Cardiovascular disease [Present vs. Not present] |
Odds ratio: 2.760 (1.390-5.450)
|
Xu
|
|
|
COVID-19 (severe/critical) |
Comorbidities |
Hypertension [Present vs. Not present] |
Odds ratio: 2.310 (1.680-3.180)
|
Xu
|
|
|
COVID-19 (severe/critical) |
Comorbidities |
Diabetes [Present vs. Not present] |
Odds ratio: 3.040 (2.010-4.600)
|
Xu
|
|
|
COVID-19 (severe/critical) |
Patient characteristics |
Smoking [Present vs. Not present] |
Odds ratio: 1.400 (0.650-3.010)
|
Xu
|
|
|
COVID-19 (severe/critical) |
Patient characteristics |
BMI [1 unit increase in BMI vs. Not applicable] |
Weighted Mean Difference: 3.380 (0.070-6.690)
|
Xu
|
|
|
COVID-19 (severe/critical) |
Laboratory Findings |
Glucose [Abnormal at admission vs. Normal] |
Odds ratio: 2.420 (1.430-4.100)
§ |
Jin
|
|
|
COVID-19 (severe/critical) |
Laboratory Findings |
LDH [Abnormal at admission vs. Normal] |
Odds ratio: 24.770 (4.600-133.330)
§ |
Jin
|
|
|
COVID-19 (severe/critical) |
Patient characteristics |
Symptoms [From infected area vs. Not applicable] |
Odds ratio: 0.090 (0.020-0.540)
§ |
Jin
|
|
|
COVID-19 (severe/critical) |
Symptoms |
Sputum production [Present vs. Not present] |
Odds ratio: 11.400 (1.890-68.730)
§ |
Jin
|
|
|
COVID-19 (severe/critical) |
Laboratory Findings |
ALT [Abnormal at admission vs. Normal] |
Odds ratio: 1.030 (0.970-1.100)
§ |
Zhang
|
|
|
COVID-19 (severe/critical) |
Laboratory Findings |
NLR [Abnormal at admission vs. Normal] |
Odds ratio: 1.490 (1.010-2.190)
§ |
Zhang
|
|
|
COVID-19 (severe/critical) |
Laboratory Findings |
NLR [Abnormal at admission vs. Normal] |
Odds ratio: 1.840 (1.140-2.980)
§ |
Zhang
|
|
|
COVID-19 (severe/critical) |
Laboratory Findings |
ALT [Abnormal at admission vs. Normal] |
Odds ratio: 1.040 (0.990-1.080)
§ |
Zhang
|
|
|
COVID-19 (severe/critical) |
Laboratory Findings |
ALT [Abnormal at admission vs. Normal] |
Odds ratio: 1.050 (1.020-1.090)
§ |
Zhang
|
|
|
COVID-19 (severe/critical) |
Patient characteristics |
Age [1 year increase vs. Not applicable] |
Odds ratio: 1.090 (1.020-1.160)
§ |
Zhang
|
|
|
COVID-19 (severe/critical) |
Patient characteristics |
Age [1 year increase vs. Not applicable] |
Odds ratio: 1.070 (1.020-1.130)
§ |
Zhang
|
|
|
COVID-19 (severe/critical) |
Patient characteristics |
Age [1 year increase vs. Not applicable] |
Odds ratio: 1.110 (1.060-1.160)
§ |
Zhang
|
|
|
SARS COV-2 infection |
Patient characteristics |
Gender [Male vs. Female] |
Odds ratio: 1.160 (1.030-1.310)
§† |
Liu
|
|
|
SARS COV-2 infection |
Patient characteristics |
Age [1 year increase vs. Not applicable] |
Odds ratio: 1.033 (1.029-1.037)
§ |
Liu
|
|
|
COVID-19 (severe/critical) |
Comorbidities |
Chronic kidney disease [Present vs. Not present] |
Odds ratio: 3.030 (1.090-8.470)
|
Henry
|
|
|
COVID-19 (severe/critical) |
Laboratory Findings |
CK-MB [Abnormal at admission vs. Normal] |
Odds ratio: 1.070 (1.010-1.140)
|
Wu
|
|
|
COVID-19 (severe/critical) |
Laboratory Findings |
D-dimer [Abnormal at admission vs. Normal] |
Odds ratio: 3.200 (1.750-5.880)
|
Wu
|
|
|
COVID-19 (severe/critical) |
Treatment |
Non-invasive ventilator (face mask) [Used vs. Not used] |
Odds ratio: 3.970 (1.580-9.930)
|
Wu
|
|
|
COVID-19 (severe/critical) |
Laboratory Findings |
Lymphocytes [Abnormal at admission vs. Normal] |
Odds ratio: 0.090 (0.020-0.290)
|
Wu
|
|
|
COVID-19 (severe/critical) |
Status |
Time from onset to treatment [1 day increase vs. Not applicable] |
Odds ratio: 26.980 (1.810-402.930)
§ |
Wu
|
|
|
COVID-19 (severe/critical) |
Status |
Time from onset to treatment [1 day increase vs. Not applicable] |
Odds ratio: 11.630 (4.510-30.030)
|
Wu
|
|
|
COVID-19 (severe/critical) |
Comorbidities |
Any comorbidity [Present vs. Not present] |
Odds ratio: 47.770 (13.680-166.770)
|
Wu
|
|
|
COVID-19 (severe/critical) |
Comorbidities |
Any comorbidity [Present vs. Not present] |
Odds ratio: 54.740 (1.140-999.990)
§ |
Wu
|
|
|
COVID-19 (severe/critical) |
Patient characteristics |
Location [Agglomerative epidemic vs. None] |
Odds ratio: 0.390 (0.240-0.650)
|
Wu
|
|
|
COVID-19 (severe/critical) |
Patient characteristics |
BMI [1 unit increase in BMI vs. Not applicable] |
Odds ratio: 1.300 (1.090-1.540)
|
Wu
|
|
|
COVID-19 (severe/critical) |
Comorbidities |
Cardiovascular disease [Present vs. Not present] |
Odds ratio: 3.420 (1.880-6.220)
† |
Yang
|
|
|
COVID-19 (severe/critical) |
Comorbidities |
Chronic respiratory disease [Present vs. Not present] |
Odds ratio: 2.460 (1.760-3.440)
† |
Yang
|
|
|
COVID-19 (severe/critical) |
Comorbidities |
Diabetes [Present vs. Not present] |
Odds ratio: 2.070 (0.890-4.820)
† |
Yang
|
|
|
COVID-19 (severe/critical) |
Comorbidities |
Hypertension [Present vs. Not present] |
Odds ratio: 2.360 (1.430-3.830)
† |
Yang
|
|
|
COVID-19 (death) |
Comorbidities |
Hypertension [Present vs. Not present] |
Odds ratio: 2.420 (1.510-3.900)
|
Lippi
|
|
|
COVID-19 (severe/critical) |
Comorbidities |
Hypertension [Present vs. Not present] |
Odds ratio: 2.490 (1.980-3.120)
|
Lippi
|
|
|